CCR News Archives
CCR News Archives
2019
- Heritable mutations may indicate responsiveness to platinum chemotherapy in malignant mesothelioma
- Undergraduate Research Scholar Program fellow continues her pursuit of science
- New clinical trial tests radiotracer for improved imaging of metastatic prostate cancer
- Clinical trial tests a PARP inhibitor in urothelial cancer with DNA-repair defects
- African Postdoctoral Training Initiative fellow looks forward to collaborating within NCI
- Envelope glycoprotein mutations allow HIV-1 to escape antiretroviral therapy in a lab-based study
- MEK inhibitor selumetinib granted breakthrough designation by FDA to treat neurofibromatosis type 1 in pediatric patients
- Elaine Jaffe receives the 2019 USCAP Board’s Distinguished Pathologist award
- New study delivers chemotherapy to the liver for metastatic colorectal cancer patients
- CCR staff receive funding from the Department of Defense
- Stephanie Goff featured in an episode of The Doctors
- New clinical trial will determine if gliomas respond to immunotherapy
- Harnessing T-cell “stemness” could enhance cancer immunotherapy
- Trial results show that younger lymphoma patients respond well to ibrutinib
- Louis Staudt elected as a fellow of the AACR Academy
- New clinical trial recruits the immune system to attack chronic lymphocytic leukemia
- CCR researchers discover how protein translation disruptions can lead to cancer
- Drug found effective in mice for uveal melanoma
- Elaine Jaffe inducted as honorary fellow of the Royal College of Pathology of Australasia
- CCR Presentations at AACR - 2019
- Deep-imaging study reveals extensive variability in 3D configuration of genomes between cells
- New strategy for treating brain tumors with mutations in metabolic enzymes
- Recap: Grand Rounds with Felicia Knaul, Ph.D.
- Researchers identify a key molecule that enhances T cell-based immunotherapy
- Steve Rosenberg receives Szent-Györgi Prize for Progress in Cancer Research
- Drug successfully treats WHIM syndrome
- Gene mutations in Burkitt lymphoma hint at more effective treatment
- CCR staff receive NCI-NIA and Curie-NCI awards
- New map of protein interactions hints at the underlying mechanisms of hereditary kidney cancer
- New insights into mechanisms key to maintaining KRAS-mutant cancer cell survival
- Clinical trial studies antitumor effect of sunitinib in central nervous system sarcomas
- Eric Freed elected fellow of the American Academy of Microbiology
- Two new compounds target a cancer-promoting RNA transcript
- Clinical trial finds combination therapy effective for some biliary cancer patients
- New imaging technology to detect early-stage hereditary diffuse gastric cancer tested in clinical trial
- Second-generation maturation inhibitors show promise for HIV treatment
- Registration now open for Chromatin and Cell Fate Decisions in Development, Aging & Cancer
- Steve Rosenberg receives 2019 Nathan Davis Award and Steinman Award
- Watch new Neuro-Oncology Branch video on NCI YouTube
2018
- Sophisticated technology reveals gene expression in real time
- Protein mutations lead to human disease by altering a cancer-promoting pathway
- New therapies tested in mice provide a one-two punch for treating liver cancer
- Study reveals function of protein crucial to survival of Staph infections
- Study reveals regions where harmful DNA breaks are most likely to occur
- Committing to cell division may be clue to cancer cell growth
- Antibody-linked drug shrinks various types of tumors in preclinical study
- FDA grants orphan drug status to selumetinib for neurofibromatosis type 1 (NF1) treatment
- Activated platelets can promote tumor cell invasion into healthy tissue
- New study shows normally helpful natural bacteria may also trigger lupus
- New clinical program will study metastatic colorectal cancer in viable patient tissue samples